Literature DB >> 33674814

Tocilizumab prevents ILD progression in early SSc.

Jessica McHugh1.   

Abstract

Entities:  

Year:  2021        PMID： 33674814     DOI： 10.1038/s41584-021-00597-z

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Tocilizumab Prevents Progression of Early Systemic Sclerosis-Associated Interstitial Lung Disease.

Authors:  David Roofeh; Celia J F Lin; Jonathan Goldin; Grace Hyun Kim; Daniel E Furst; Christopher P Denton; Suiyuan Huang; Dinesh Khanna
Journal:  Arthritis Rheumatol       Date:  2021-05-25       Impact factor: 15.483
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.